These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 33930473)
1. Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies. Bubonja-Šonje M; Batičić L; Abram M; Cekinović Grbeša Đ J Virol Methods; 2021 Jul; 293():114173. PubMed ID: 33930473 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays. Harley K; Gunsolus IL J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364 [TBL] [Abstract][Full Text] [Related]
3. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients. Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000 [TBL] [Abstract][Full Text] [Related]
5. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers. Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test. Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695 [TBL] [Abstract][Full Text] [Related]
7. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls. Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect. Maine GN; Lao KM; Krishnan SM; Afolayan-Oloye O; Fatemi S; Kumar S; VanHorn L; Hurand A; Sykes E; Sun Q J Clin Virol; 2020 Dec; 133():104663. PubMed ID: 33161369 [TBL] [Abstract][Full Text] [Related]
9. Assessment of commercial SARS-CoV-2 antibody assays, Jamaica. Butterfield TR; Bruce-Mowatt A; Phillips YZR; Brown N; Francis K; Brown J; Walker JP; McKnight NAL; Ehikhametalor K; Taylor DK; Bruce CA; McGrowder D; Wharfe G; Sandiford SL; Thompson TK; Anzinger JJ Int J Infect Dis; 2021 Apr; 105():333-336. PubMed ID: 33610776 [TBL] [Abstract][Full Text] [Related]
10. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics. Jalkanen P; Pasternack A; Maljanen S; Melén K; Kolehmainen P; Huttunen M; Lundberg R; Tripathi L; Khan H; Ritvos MA; Naves R; Haveri A; Österlund P; Kuivanen S; Jääskeläinen AJ; Kurkela S; Lappalainen M; Rantasärkkä K; Vuorinen T; Hytönen J; Waris M; Tauriainen S; Ritvos O; Kakkola L; Julkunen I J Infect Dis; 2021 Jul; 224(2):218-228. PubMed ID: 33905505 [TBL] [Abstract][Full Text] [Related]
11. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2. Nedelcu I; Jipa R; Vasilescu R; Băicuș C; Popescu CI; Manea E; Stoichițoiu LE; Pinte L; Damalan A; Simulescu O; Stoica I; Stoica M; Hristea A Viruses; 2021 Jun; 13(7):. PubMed ID: 34206895 [TBL] [Abstract][Full Text] [Related]
13. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies. Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19. Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays. Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195 [TBL] [Abstract][Full Text] [Related]
18. Comparison of various serological assays for novel SARS-COV-2. Sacristan MS; Collazos-Blanco A; Cintas MIZ; García AS; de Villavicencio CY; Maestre MM Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):963-968. PubMed ID: 33236270 [TBL] [Abstract][Full Text] [Related]
19. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study. Al-Mughales JA; Al-Mughales TJ; Saadah OI Front Immunol; 2021; 12():705441. PubMed ID: 34539635 [TBL] [Abstract][Full Text] [Related]